Global /Hong Kong /Healthcare /Biotechnology /1011

China NT Pharma Group Company Ltd.

1011

• SHEK: 1011 • Delayed

0.6500HKD -3%

0.0829 USD

As of 14 June 2026, China NT Pharma Group Company Ltd. has a market cap of $81.13M USD, ranking #27030 globally and #577 in Hong Kong. It ranks #2422 in the Healthcare sector, and #466 in the Biotechnology industry.

Global Rank

27030

Country Rank

577

Sector Rank

2422

Industry Rank

466

Key Stats

Market Cap

$81.13MUSD

635.83M HKD

Enterprise Value

$125.06MUSD

979.98M HKD

Revenue (TTM)

$3.43MUSD

26.88M HKD

EBITDA (TTM)

-$1.75MUSD

-13.71M HKD

Net Income (TTM)

-$3.7MUSD

-28.98M HKD

EBITDA Margin

-51%

Profit Margin

-108%

PS Ratio

23.7

PB Ratio

-2.1

Company Profile

Country (HQ)

Hong Kong

Sector

Healthcare

Industry

Biotechnology

CEO

Bozhi Zhang open_in_new

Employees

Founded

1995

Website

ntpharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3%	-16%	-8.5%	-20%	-18%	-21%	49%	10%	-48%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	1011 中国泰凌医药集团有限公司 ISIN: KYG2114L1133 Shares Out.: Shares Outstanding: 948.998M¹ Shares Float: 728.198M² TV: TradingView: HKEX: 1011 SA: Stock Analysis: HKG: 1011 YF: Yahoo Finance: 1011.HK GF: Google Finance: HKG: 1011 BA: Barron's: 1011 MS: Morningstar: XHKG: 01011	0.6500 HKD	TV: TradingView: HKEX: 1011 SA: Stock Analysis: HKG: 1011 YF: Yahoo Finance: 1011.HK GF: Google Finance: HKG: 1011 BA: Barron's: 1011 MS: Morningstar: XHKG: 01011

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About China NT Pharma Group Company Ltd.

China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China. It operates through Digital Services and Sales Agency Service segments. The company acts as agent for clients to sell medical and health-related products to external customers. It also provides marketing and promotion in relation to bone health knowledge. In addition, the company is involved in trading of prescription medicines; and provision of consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Central, Hong Kong.

Similar Companies

Industry: Biotechnology (Hong Kong)

Name	Market Cap (USD) diff.	PE	Country
SinoMab BioScience Ltd. SHEK: 3681	$270.7M 2.12B HKD 234%	-	Hong Kong
Chia Tai Enterprises International Ltd. SHEK: 3839	$265.38M 2.08B HKD 227%	8.3	Hong Kong
Sirnaomics Ltd. SHEK: 2257	$91.57M 717.64M HKD 13%	-	Hong Kong

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 225K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 197K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 59K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 55K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 52K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 52K%	37.2	Switzerland

chevron_leftBack